Core Viewpoint - The company has recently received two invention patent certificates from the National Intellectual Property Administration and the Japan Patent Office, indicating advancements in its technology related to sample analysis and nucleic acid testing [1] Group 1 - The company announced the receipt of an invention patent certificate for a reagent dispensing device and a sample analysis instrument [1] - The company also received a patent for a substance extraction device and a nucleic acid testing integrated machine [1]

Core Viewpoint - The company has recently received two invention patent certificates from the National Intellectual Property Administration of China and the Japan Patent Office, indicating advancements in its technology and potential for future growth in the biomedical field [2] Company Summary - Shenzhen New Industry Biomedical Engineering Co., Ltd. announced the receipt of two invention patents, titled "Reagent Injection Device and Sample Analyzer with It" and "Test Substance Extraction Device and Nucleic Acid Detection Integrated Machine" [2] - For the fiscal year 2024, the company's revenue composition is heavily weighted towards in vitro diagnostics, accounting for 99.82% of total revenue, while other business segments contribute only 0.18% [2]